 | • レポートコード：B-GIR08C0811 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、癌二重特異性抗体の世界市場について調べ、まとめました。種類別セグメントは、CD19/CD3、 CD30/CD16A等、用途別セグメントは、病院、製薬会社、その他等に区分しました。癌二重特異性抗体の世界市場概観、企業動向、企業別癌二重特異性抗体シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・癌二重特異性抗体の市場概観 ・癌二重特異性抗体の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・癌二重特異性抗体の企業別販売動向、市場シェア、市場集中度、競争動向 ・癌二重特異性抗体の世界市場規模 ・癌二重特異性抗体の北米市場分析（アメリカ、カナダ、メキシコ等） ・癌二重特異性抗体のアメリカ市場規模推移 ・癌二重特異性抗体のカナダ市場規模推移 ・癌二重特異性抗体のメキシコ市場規模推移 ・癌二重特異性抗体のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・癌二重特異性抗体のドイツ市場規模推移 ・癌二重特異性抗体のイギリス市場規模推移 ・癌二重特異性抗体のロシア市場規模推移 ・癌二重特異性抗体のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・癌二重特異性抗体の日本市場規模推移 ・癌二重特異性抗体の中国市場規模推移 ・癌二重特異性抗体の韓国市場規模推移 ・癌二重特異性抗体のインド市場規模推移 ・癌二重特異性抗体の東南アジア市場規模推移 ・癌二重特異性抗体の南米市場分析（ブラジル、アルゼンチン等） ・癌二重特異性抗体の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・癌二重特異性抗体の種類別分析/販売量、売上、市場シェア（CD19/CD3、 CD30/CD16A） ・癌二重特異性抗体の用途別分析/市場規模（病院、製薬会社、その他） ・癌二重特異性抗体の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・癌二重特異性抗体の販売チャネル・代理店・貿易業者・ディーラー分析 |
Bispecific antibodies can simultaneously address two different antigens, which are sufficient to target two trails involved in cancer pathogenesis, and therefore, provide advantages over monoclonal antibodies therapy.
Scope of the Report:
The worldwide market for Bispecific Antibodies for Cancer is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Bispecific Antibodies for Cancer in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Amgen
Astella Pharma
Ben Kang Biopharmaceutical (Shenzhen)
Merus
Regeneron Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
CD19/CD3
CD30/CD16A
Market Segment by Applications, can be divided into
Hospital
Pharmaceutical Companies
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bispecific Antibodies for Cancer product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bispecific Antibodies for Cancer, with price, sales, revenue and global market share of Bispecific Antibodies for Cancer in 2017 and 2018.
Chapter 3, the Bispecific Antibodies for Cancer competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bispecific Antibodies for Cancer breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Bispecific Antibodies for Cancer market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Bispecific Antibodies for Cancer sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Bispecific Antibodies for Cancer Introduction
1.2 Market Analysis by Type
1.2.1 CD19/CD3
1.2.2 CD30/CD16A
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Pharmaceutical Companies
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Bispecific Antibodies for Cancer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Astella Pharma
2.2.1 Business Overview
2.2.2 Bispecific Antibodies for Cancer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Astella Pharma Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Ben Kang Biopharmaceutical (Shenzhen)
2.3.1 Business Overview
2.3.2 Bispecific Antibodies for Cancer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Merus
2.4.1 Business Overview
2.4.2 Bispecific Antibodies for Cancer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merus Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Regeneron Pharmaceuticals
2.5.1 Business Overview
2.5.2 Bispecific Antibodies for Cancer Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Bispecific Antibodies for Cancer Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Bispecific Antibodies for Cancer Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Bispecific Antibodies for Cancer Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Bispecific Antibodies for Cancer Manufacturer Market Share in 2018
3.3.2 Top 6 Bispecific Antibodies for Cancer Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Bispecific Antibodies for Cancer Market Analysis by Regions
4.1 Global Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Regions
4.1.1 Global Bispecific Antibodies for Cancer Sales and Market Share by Regions (2014-2019)
4.1.2 Global Bispecific Antibodies for Cancer Revenue and Market Share by Regions (2014-2019)
4.2 North America Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
4.3 Europe Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
4.5 South America Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
5 North America Bispecific Antibodies for Cancer by Country
5.1 North America Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Country
5.1.1 North America Bispecific Antibodies for Cancer Sales and Market Share by Country (2014-2019)
5.1.2 North America Bispecific Antibodies for Cancer Revenue and Market Share by Country (2014-2019)
5.2 United States Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
5.3 Canada Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
5.4 Mexico Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
6 Europe Bispecific Antibodies for Cancer by Country
6.1 Europe Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Country
6.1.1 Europe Bispecific Antibodies for Cancer Sales and Market Share by Country (2014-2019)
6.1.2 Europe Bispecific Antibodies for Cancer Revenue and Market Share by Country (2014-2019)
6.2 Germany Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
6.3 UK Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
6.4 France Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
6.5 Russia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
6.6 Italy Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
7 Asia-Pacific Bispecific Antibodies for Cancer by Country
7.1 Asia-Pacific Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Bispecific Antibodies for Cancer Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Bispecific Antibodies for Cancer Revenue and Market Share by Country (2014-2019)
7.2 China Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
7.3 Japan Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
7.4 Korea Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
7.5 India Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
8 South America Bispecific Antibodies for Cancer by Country
8.1 South America Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Country
8.1.1 South America Bispecific Antibodies for Cancer Sales and Market Share by Country (2014-2019)
8.1.2 South America Bispecific Antibodies for Cancer Revenue and Market Share by Country (2014-2019)
8.2 Brazil Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
8.3 Argentina Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
8.4 Colombia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
9 Middle East and Africa Bispecific Antibodies for Cancer by Countries
9.1 Middle East and Africa Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Bispecific Antibodies for Cancer Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Bispecific Antibodies for Cancer Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
9.3 Turkey Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
9.4 Egypt Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
9.5 Nigeria Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
9.6 South Africa Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
10 Global Bispecific Antibodies for Cancer Market Segment by Type
10.1 Global Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Bispecific Antibodies for Cancer Sales and Market Share by Type (2014-2019)
10.1.2 Global Bispecific Antibodies for Cancer Revenue and Market Share by Type (2014-2019)
10.2 CD19/CD3 Sales Growth and Price
10.2.1 Global CD19/CD3 Sales Growth (2014-2019)
10.2.2 Global CD19/CD3 Price (2014-2019)
10.3 CD30/CD16A Sales Growth and Price
10.3.1 Global CD30/CD16A Sales Growth (2014-2019)
10.3.2 Global CD30/CD16A Price (2014-2019)
11 Global Bispecific Antibodies for Cancer Market Segment by Application
11.1 Global Bispecific Antibodies for Cancer Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Pharmaceutical Companies Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Bispecific Antibodies for Cancer Market Forecast (2019-2024)
12.1 Global Bispecific Antibodies for Cancer Sales, Revenue and Growth Rate (2019-2024)
12.2 Bispecific Antibodies for Cancer Market Forecast by Regions (2019-2024)
12.2.1 North America Bispecific Antibodies for Cancer Market Forecast (2019-2024)
12.2.2 Europe Bispecific Antibodies for Cancer Market Forecast (2019-2024)
12.2.3 Asia-Pacific Bispecific Antibodies for Cancer Market Forecast (2019-2024)
12.2.4 South America Bispecific Antibodies for Cancer Market Forecast (2019-2024)
12.2.5 Middle East and Africa Bispecific Antibodies for Cancer Market Forecast (2019-2024)
12.3 Bispecific Antibodies for Cancer Market Forecast by Type (2019-2024)
12.3.1 Global Bispecific Antibodies for Cancer Sales Forecast by Type (2019-2024)
12.3.2 Global Bispecific Antibodies for Cancer Market Share Forecast by Type (2019-2024)
12.4 Bispecific Antibodies for Cancer Market Forecast by Application (2019-2024)
12.4.1 Global Bispecific Antibodies for Cancer Sales Forecast by Application (2019-2024)
12.4.2 Global Bispecific Antibodies for Cancer Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Bispecific Antibodies for Cancer Picture
Table Product Specifications of Bispecific Antibodies for Cancer
Figure Global Sales Market Share of Bispecific Antibodies for Cancer by Types in 2018
Table Bispecific Antibodies for Cancer Types for Major Manufacturers
Figure CD19/CD3 Picture
Figure CD30/CD16A Picture
Figure Bispecific Antibodies for Cancer Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Pharmaceutical Companies Picture
Figure Other Picture
Figure United States Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure France Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure UK Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure China Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure India Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Bispecific Antibodies for Cancer Revenue (Value) and Growth Rate (2014-2024)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Bispecific Antibodies for Cancer Type and Applications
Table Amgen Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Astella Pharma Basic Information, Manufacturing Base and Competitors
Table Astella Pharma Bispecific Antibodies for Cancer Type and Applications
Table Astella Pharma Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ben Kang Biopharmaceutical (Shenzhen) Basic Information, Manufacturing Base and Competitors
Table Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Type and Applications
Table Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merus Basic Information, Manufacturing Base and Competitors
Table Merus Bispecific Antibodies for Cancer Type and Applications
Table Merus Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Type and Applications
Table Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Bispecific Antibodies for Cancer Sales by Manufacturer (2017-2018)
Figure Global Bispecific Antibodies for Cancer Sales Market Share by Manufacturer in 2017
Figure Global Bispecific Antibodies for Cancer Sales Market Share by Manufacturer in 2018
Table Global Bispecific Antibodies for Cancer Revenue by Manufacturer (2017-2018)
Figure Global Bispecific Antibodies for Cancer Revenue Market Share by Manufacturer in 2017
Figure Global Bispecific Antibodies for Cancer Revenue Market Share by Manufacturer in 2018
Figure Top 3 Bispecific Antibodies for Cancer Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Bispecific Antibodies for Cancer Manufacturer (Revenue) Market Share in 2018
Figure Global Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Global Bispecific Antibodies for Cancer Revenue and Growth Rate (2014-2019)
Table Global Bispecific Antibodies for Cancer Sales by Regions (2014-2019)
Table Global Bispecific Antibodies for Cancer Sales Market Share by Regions (2014-2019)
Table Global Bispecific Antibodies for Cancer Revenue by Regions (2014-2019)
Figure Global Bispecific Antibodies for Cancer Revenue Market Share by Regions (2014-2019)
Figure Global Bispecific Antibodies for Cancer Revenue Market Share by Regions in 2018
Figure North America Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Europe Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure South America Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure North America Bispecific Antibodies for Cancer Revenue and Growth Rate (2014-2019)
Table North America Bispecific Antibodies for Cancer Sales by Countries (2014-2019)
Table North America Bispecific Antibodies for Cancer Sales Market Share by Countries (2014-2019)
Figure North America Bispecific Antibodies for Cancer Sales Market Share by Countries (2014-2019)
Figure North America Bispecific Antibodies for Cancer Sales Market Share by Countries in 2018
Table North America Bispecific Antibodies for Cancer Revenue by Countries (2014-2019)
Table North America Bispecific Antibodies for Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Bispecific Antibodies for Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Bispecific Antibodies for Cancer Revenue Market Share by Countries in 2018
Figure United States Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Canada Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Mexico Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Europe Bispecific Antibodies for Cancer Revenue and Growth Rate (2014-2019)
Table Europe Bispecific Antibodies for Cancer Sales by Countries (2014-2019)
Table Europe Bispecific Antibodies for Cancer Sales Market Share by Countries (2014-2019)
Table Europe Bispecific Antibodies for Cancer Revenue by Countries (2014-2019)
Figure Europe Bispecific Antibodies for Cancer Revenue Market Share by Countries (2014-2019)
Figure Europe Bispecific Antibodies for Cancer Revenue Market Share by Countries in 2018
Figure Germany Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure UK Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure France Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Russia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Italy Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Bispecific Antibodies for Cancer Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Bispecific Antibodies for Cancer Sales by Countries (2014-2019)
Table Asia-Pacific Bispecific Antibodies for Cancer Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Bispecific Antibodies for Cancer Sales Market Share by Countries 2018
Table Asia-Pacific Bispecific Antibodies for Cancer Revenue by Countries (2014-2019)
Figure Asia-Pacific Bispecific Antibodies for Cancer Revenue Market Share by Countries 2018
Figure China Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Japan Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Korea Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure India Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Southeast Asia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure South America Bispecific Antibodies for Cancer Revenue and Growth Rate (2014-2019)
Table South America Bispecific Antibodies for Cancer Sales by Countries (2014-2019)
Table South America Bispecific Antibodies for Cancer Sales Market Share by Countries (2014-2019)
Figure South America Bispecific Antibodies for Cancer Sales Market Share by Countries in 2018
Table South America Bispecific Antibodies for Cancer Revenue by Countries (2014-2019)
Table South America Bispecific Antibodies for Cancer Revenue Market Share by Countries (2014-2019)
Figure South America Bispecific Antibodies for Cancer Revenue Market Share by Countries in 2018
Figure Brazil Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Argentina Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Colombia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Bispecific Antibodies for Cancer Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Bispecific Antibodies for Cancer Sales by Countries (2014-2019)
Table Middle East and Africa Bispecific Antibodies for Cancer Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Bispecific Antibodies for Cancer Sales Market Share by Countries in 2018
Table Middle East and Africa Bispecific Antibodies for Cancer Revenue by Countries (2014-2019)
Table Middle East and Africa Bispecific Antibodies for Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Bispecific Antibodies for Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Bispecific Antibodies for Cancer Revenue Market Share by Countries in 2018
Figure Saudi Arabia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure UAE Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Egypt Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure Nigeria Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Figure South Africa Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)
Table Global Bispecific Antibodies for Cancer Sales by Type (2014-2019)
Table Global Bispecific Antibodies for Cancer Sales Share by Type (2014-2019)
Table Global Bispecific Antibodies for Cancer Revenue by Type (2014-2019)
Table Global Bispecific Antibodies for Cancer Revenue Share by Type (2014-2019)
Figure Global CD19/CD3 Sales Growth (2014-2019)
Figure Global CD19/CD3 Price (2014-2019)
Figure Global CD30/CD16A Sales Growth (2014-2019)
Figure Global CD30/CD16A Price (2014-2019)
Table Global Bispecific Antibodies for Cancer Sales by Application (2014-2019)
Table Global Bispecific Antibodies for Cancer Sales Share by Application (2014-2019)
Figure Global Pharmaceutical Companies Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Bispecific Antibodies for Cancer Sales, Revenue and Growth Rate (2019-2024)
Table Global Bispecific Antibodies for Cancer Sales Forecast by Regions (2019-2024)
Table Global Bispecific Antibodies for Cancer Market Share Forecast by Regions (2019-2024)
Figure North America Sales Bispecific Antibodies for Cancer Market Forecast (2019-2024)
Figure Europe Sales Bispecific Antibodies for Cancer Market Forecast (2019-2024)
Figure Asia-Pacific Sales Bispecific Antibodies for Cancer Market Forecast (2019-2024)
Figure South America Sales Bispecific Antibodies for Cancer Market Forecast (2019-2024)
Figure Middle East and Africa Sales Bispecific Antibodies for Cancer Market Forecast (2019-2024)
Table Global Bispecific Antibodies for Cancer Sales Forecast by Type (2019-2024)
Table Global Bispecific Antibodies for Cancer Market Share Forecast by Type (2019-2024)
Table Global Bispecific Antibodies for Cancer Sales Forecast by Application (2019-2024)
Table Global Bispecific Antibodies for Cancer Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
がん標的療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Cancer Targeted Therapy market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast g…- がん免疫療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer. Scope of the Report: The global Cancer Immunotherapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a…
- がん生物製剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Cancer Biologic is a medicinal preparation created by a biological process, it is used to treatment and remission cancer symptoms. Scope of the Report: The global Cancer Biologics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR…
- 乳がん用アロマターゼ阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Aromatase Inhibitors for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…
- 乳癌用ER標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global ER Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…